Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice

Neuroscience Research

Volumn 35, Issue 2, 1999, Pages 77-83

  Yamaguchi, Tomomi ^a   Nagasawa, Tetsuro ^b   Satoh, Masamichi ^c   Kuraishi, Yasushi ^a  

^a Fac Pharmaceutical Sci   (Japan)

^b Inst Nat Med   (Japan)

^c Grad Sch Pharmaceutical Sci   (Japan)

Author keywords

Capsaicin; Mouse; Naloxone; Pruritus; Scratching; Serotonin receptor subtype

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 METHYLSEROTONIN; CAPSAICIN; CYPROHEPTADINE; METHYSERGIDE; NALOXONE; PHENYLBIGUANIDE; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; SCRATCHING; SKIN SENSATION; SKIN STIMULATION;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; INJECTIONS, INTRADERMAL; MALE; MICE; MICE, INBRED STRAINS; NALOXONE; NARCOTIC ANTAGONISTS; PRURITUS; REACTION TIME; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0032703315     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00070-X     Document Type: Article

References (42)

1. 1 tachykinin receptors in mice. J. Pharmacol. Exp. Ther. 286:1998;1140-1145.
2. Armstrong D., Dry R.M.L., Keele C.A., Markham J.W. Observation on chemical excitants of cutaneous pain in man. J. Physiol. 120:1953;326-351.
3. Arzt E., Costas M., Finkielman S., Nahmod V.E. Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Sci. 48:1991;2557-2562.
4. Ballantyne J.C., Loach A.B., Carr D.B. Itching after epidural and spinal opiates. Pain. 33:1988;149-160.
5. Bergasa N.V., Alling D.W., Talbot T.L., Swain M.G., Yurdaydin C., Turner M.L., Walker E.C., Jones E.A. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann. Intern. Med. 123:1995;161-167.
6. Bergasa N.V., Talbot T.L., Alling D.W., Schmitt J.M., Walker E.C., Baker B.L., Korenman J.C., Park Y., Hoofnagle J.H., Jones E.A. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology. 102:1992;544-549.
7. Bernstein J.E., Swift R.M., Soltani K., Lorincz A.L. Antipruritic effect of an opiate antagonist, naloxone hydrochloride. J. Invest. Dermatol. 78:1982;82-83.
8. Breneman D.L., Cardone J.S., Blumsack R.F., Lather R.M., Searle E.A., Pollack V.E. Topical capsaicin for treatment of hemodialysis-related pruritus. J. Am. Acad. Dermatol. 26:1992;91-94.
9. Carlton S.M., Coggeshall R.E. Immunohistochemical localization of 5-HT2A receptors in peripheral sensory axons in rat glabrous skin. Brain Res. 763:1997;271-275.
10. Crighton I.M., Hobbs G.J., Reid M.F. Ondansetron for the treatment of pruritus after spinal opioids. Anaesthesia. 51:1996;199-200.
11. Ellis C.N., Berberian B., Sulica V.I., Dodd W.A., Jarratt M.T., Katz H.I., Prawer S., Krueger G., Rex I.H.J.r., Wolf J.E. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J. Am. Acad. Dermatol. 29:1994;438-442.
12. Fitzsimons E.J., Dagg J.H., McAllister E.J. Pruritus of polycythaemia vera: a place for pizotifen? Br. Med. J. 283:1981;277-277.
13. Fjellner B., Hägermark Ö. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Dermatovener. 59:1979;505-512.
14. Fjellner B., Hägermark Ö. The influence of the opiate antagonist naloxone on experimental pruritus. Acta Derm. Venereol. 64:1983;73-75.
15. Fujii E., Irie K., Uchida Y., Tsukahara F., Muraki T. Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;361-364.
16. Hagiwara K., Nojima H., Kuraishi Y. Serotonin-induced biting of the hind paw is itch-related response in mice. Pain Res. 14:1999;53-59.
17. Jacob J.J., Ramabadran K. Enhancement of a nociceptive reaction by opioid antagonists in mice. Br. J. Pharmacol. 64:1978;91-98.
18. Keele C.A., Armstrong D. Substances Producing Pain and Itch. 1964;Willimas and Wilkins, Baltimore.
19. Kitagawa K., Andoh, T., Nagasawa, T., Satoh, M., Kuraishi, Y., 1997. Different effects of antagonists to histamine and serotonin receptors on itch-related behavior induced by substance P, histamine and serotonin in mice. Jpn. J. Pharmacol. 73 (Suppl. I), 93p.
20. Kuraishi Y., Nagasawa T., Hayashi K., Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275:1995;229-233.
21. Maurer M., Opitz M., Henz B.M., Paus R. The mast cell products histamine and serotonin stimulate and TNF-α inhibits the proliferation of murine epidermal keratinocytes in situ. J. Dermatol. Sci. 16:1997;79-84.
22. McMahon S.B., Koltzenburg M. Itching for an explanation. Trends Neurosci. 15:1992;497-501.
23. Monroe E.W. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. J. Am. Acad. Dermatol. 21:1989;135-136.
24. Penning J.P., Samson B., Baxter A.D. Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine. Can. J. Anaesth. 35(6):1988;599-604.
25. Pierce P.A., Xie G.X., Levine J.D., Peroutka S.J. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience. 70:1996;553-559.
26. Raderer M., Müller C., Scheithauer W. Ondansetron for pruritus due to cholestasis. N. Engl. J. Med. 330:1994;1540-1540.
27. Saiah M., Borgeat A., Wilder-Smith O.H.G., Rifat K., Suter P.M. Epidural-morphine-induced pruritus: propofol versus naloxone. Anesth. Analg. 78:1994;1110-1113.
28. Schwörer H., Hartman H., Ramadori G. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain. 61:1995;33-37.
29. Schwörer H., Ramadori G. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. Clin. Invest. 71:1993;659-662.
30. Shelley W.B., Arthur R.P. The neurohistology and neurophysiology of the itch sensation in man. Arch. Dermatol. 76:1957;296-323.
31. Sugimoto M., Kuraishi Y., Satoh M., Takagi H. Enhancement of a nociceptive reaction by opioid antagonists in mice. Neuropharmacology. 25:1986;481-485.
32. Summerfield J.A. Naloxone modulates the perception of itch in man. Br. J. Clin. Pharmacol. 10:1980;180-183.
33. Szeimies R.-M., Stolz W., Wlotzke U., Korting H.C., Landthaler M. Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br. J. Dermatol. 131:1994;380-382.
34. 3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons. Brain Res. 511:1990;71-79.
35. Thomas D.A., Hammond D.L. Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching. Brain Res. 695:1995;267-270.
36. Thomas D.A., Williams G.M., Iwata K., Kenshalo D.R. Jr, Dubner R. Effects of central administration of opioids on facial scratching in monkeys. Brain Res. 585:1992;315-317.
37. Tohda C., Yamaguchi T., Kuraishi Y. Intracisternal injection of opioids induces itch-associated response through μ-opioid receptors in mice. Jpn. J. Pharmacol. 74:1997;74-77.
38. Tóth-Kasa I., Jancso G., Bognar A., Husz S., Obal F.J.r. Capsaicin prevents histamine-induced itching. Int. J. Clin. Pharmacol. Res. 6:1986;163-169.
39. Wallengren J. Treatment of notalgia paresthetica with topical capsaicin. J. Am. Acad. Dermatol. 24:1991;286-288.
40. Wahlgren C.-F., Ekblom A. Perception of histamine-induced itch elicited in three different skin regions. Acta Dermatovener. 71:1991;205-208.
41. Weisshaar E., Ziethen B., Gollnick H. Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch. Inflamm. Res. 46:1997;412-416.
42. Young M.R., Matthews J.P. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology. 84:1995;148-152.